Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Science Advances|January 20, 2018
Experimenter gender and replicability in scienceColin D Chapman, Christian Benedict, Helgi B Schiöth
Sleep Medicine Reviews|December 14, 2017
Association between long sleep duration and increased risk of obesity and type 2 diabetes: A review of possible mechanismsXiao Tan, Colin D Chapman, Jonathan Cedernaes, et al.
Neuropharmacology|November 29, 2017
Intranasal insulin in Alzheimer's disease: Food for thoughtColin D Chapman, Helgi B Schiöth, Claudia A Grillo, et al.
The Lancet. Diabetes & Endocrinology|August 29, 2017
Aiding sleep in type 2 diabetes: therapeutic considerationsXiao Tan, Lieve van Egmond, Colin D Chapman, et al.
Pharmacology, Biochemistry, and Behavior|June 25, 2010
Hypothalamic paraventricular 5-hydroxytryptamine inhibits the effects of ghrelin on eating and energy substrate utilizationPaul J Currie, Catherine S John, Marjorie L Nicholson, et al.
Pharmaceutical Research|November 9, 2012
Intranasal treatment of central nervous system dysfunction in humansColin D Chapman, William H Frey, Suzanne Craft, et al.
Neuroreport|March 8, 2012
Paraventricular nucleus anandamide signaling alters eating and substrate oxidationColin D Chapman, Lindsey M Dono, Matthew C French, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 20, 2017
Central effects of insulin detemir on feeding, body weight, and metabolism in ratsJoseph R Vasselli, F Xavier Pi-Sunyer, Daniel G Wall, et al.
Behavioural Brain Research|September 13, 2011
Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamusPaul J Currie, Renata Khelemsky, Elizabeth M Rigsbee, et al.
Plos One|July 2, 2014
Watching TV and food intake: the role of contentColin D Chapman, Victor C Nilsson, Hanna Å Thune, et al.
Pageof 2